Recent

% | $
Quotes you view appear here for quick access.

Avanir Pharmaceuticals, Inc. Message Board

  • reetchbeetch reetchbeetch Aug 10, 2012 7:29 PM Flag

    Avanir Facts Revealed - Truth Only

    Pumpers have been here for 2 years luring nieve investors to buy above $3 and $4 and even Tradestoxx who was convincing you to buy above $5 in November 2010.

    The problem isn't the so called bashers or even the shorts the problem is the facts.
    Just look at what this stock did last year heading into December. If you can't see this happening again you are blind.
    http://www.nasdaq.com/symbol/avnr/interactive-chart?timeframe=1y

    You have a company with $10 million in revenues and $15 million in losses every quarter that has somehow garnered a $400,000,000 market cap. I'm pretty sure that you can't survive as a company losing that much money every quarter and it looks like a failed business plan that has been 10 years in the making.

    This company just renewed their shelf registration to dilute by another $100 million in outstanding shares and if their past is any indication of their future you have to factor that in to the share price. Their are also around 1 million warrants just waiting to be exercised diluting this even further.
    $400,000,000/135,000,000 shares = $2.96
    $400,000,000/145,000,000 shares = $2.75
    $400,000,000/200,000,000 shares = $2.00

    Further dilution has ruined this pig and with the same market cap look at where this stock could be.
    Remember the good ol days when we had 87 million outstanding shares just 2 years ago?
    $400,000,000/87,000,000 shares = $4.60

    Q1 2012 -- NetLoss -- $(15,946,157)
    Q2 2012 -- NetLoss -- $(17,050,116)
    Q3 2012 -- NetLoss -- $(15,030,214)
    Right on track for another year exceeding $60 million in losses.

    Consistent Dilution form the CEO and BOD's.
    Date ------ Outstanding Shares
    Sep 2006 -- 30,634,872
    Sep 2007 -- 39,643,876
    Sep 2008 -- 58,901,030
    Sep 2009 -- 78,844,251
    Sep 2010 -- 87,614,420
    Dec 2010 -- 108,396,709
    Mar 2011 -- 121,635,339
    Jun 2011 -- 123,354,986
    Sep 2011 -- 124,325,299
    Dec 2011 -- 132,467,537
    Feb 2012 -- 135,684,912
    Jun 2012 -- 135,825,005
    Currently well over 145,000,000 if you count the stock options not yet exercised.

    Consistent Annual Losses
    2005 -- NetLoss -- ($30,606,564)
    2006 -- NetLoss -- ($62,552,814)
    2007 -- NetLoss -- ($20,933,453)
    2008 -- NetLoss -- ($17,495,739)
    2009 -- NetLoss -- ($21,996,016)
    2010 -- NetLoss -- ($26,694,148)
    2011 -- NetLoss -- ($60,631,563)
    2012 -- Net Loss Estimated -- ($60,000,000)

    Avanir is a bad investment plain and simple. Not profitable, no dividend, and last but not least a greedy CEO and BOD's.

    Weekly script growth has been stagnant between 2,000 and 2,200 since May which revenues isnt growing enough to cover expenses or the growing share count.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AVNR
16.960.00(0.00%)Jan 12 3:59 PMEST